logo
    bjectives:To evaluate the effect of So1ution-Focused Brief Therapy(SFBT) combined with paroxetine in the treatment of Obsessive-Compulsive Disorder(OCD). Methods:60 outpatients who met CCMD-3 criteria for OCD were randomly divided into experiment group (SFBT plus Paroxetine,n=30)and control group (paroxetine only,n=30) and treated for 10 weeks. The efficacy was assessed with Yale-Brown 0bsessive- Compulsive Rating Scale (Y-BOCS) at the end of week 2,4,6,8,and 10. Results:The Y-BOCS score in two groups were significantly decreased 2,4,6,8,and 10 weeks after treatment (P0.05 or P0.01),and the Y-BOCS score in experiment group was significantly lower than that in control group (P0.05 or P0.01). Conclusions: SFBT combined with paroxetine and paroxetine have significant efficacy in the treatment of OCD,and SFBT combined with paroxetine has better effect than paroxetine alone.
    Paroxetine
    Citations (6)
    Objective:To evaluate the efficacy and safety of paroxetine in the treatment of depression.Methods:63 patients with depression were randomly divided into the treatment groups of paroxetine or imipramine for 6 weeks.HAMD were adopted to evaluate the therapeutie effect.TESS was used to assess the side effects.Results:The effective rate in paroxetine group was 87.5%.No significant difference was found between the two groups.The adverse efffects of paroxetine were less and mild.Conclusions:Paroxetine is an effective antidepressant in treating depression.
    Paroxetine
    Depression
    Citations (1)
    Objective To compare the curative effects and the adverse effects between Paroxetine and Fluoxetine.Methods According to CCMD-3,there were 60 samples from patients of depression who were stochastically group in two sets.They were treated by Paroxetine and Fluoxetine in 6 weeks with dose 20mg/d.Results The effective power of Paroxetine is 83.3%.The effective power of Fluoxetine is 76.7%.According to HAMD,the curative effects of Paroxetine are obvious in 1 week.Fluoxetine's are in 4 weeks.Paroxetine is better.Conclusion Paroxetine's adverse effects are less.Curative effects of Paroxetine are better than neotype antidepressants.
    Paroxetine
    Depression
    Citations (1)
    Summary The tolerability and safety of treatment with paroxetine have been assessed by analysis of a clinical trial database that extends to 4126 patients treated with paroxetine, 1954 patients on active control, and 625 placebo patients. A total of 451 patients were exposed to paroxetine for periods of 1 or more years. Paroxetine was generally better tolerated than active control and was associated with a lower frequency of manic reactions in bipolar patients and fewer seizures than active control. Paroxetine appears to offer a differential advantage in reducing suicidal thoughts; the number of suicides and attempted suicides per patient exposure year were lower for paroxetine than for other antidepressants or placebo.
    Paroxetine
    Tolerability
    Citations (3)
    Objective:To evaluate the efficacy and safety of paroxetine in the treatment of general anxiety disorder(GAD).Methods : 60 patients with GAD were randomly assigned into the treatment groups of paroxetine or Doxepine for 6 weeks.HAMA.CGI were adopted to evaluate the therapeutic response.TESS were used to assess the side effects.Results: 83.33 % of patients responded to paroxetine.No significant difference was found between the groups.The adverse effects of paroxetine were less and mild.Conclusions: paroxetine is effectiver in treating GAD.
    Paroxetine
    Citations (0)
    Objective:To evaluate the efficacy and safety of Relaxation training combined with Paroxetine in the treatment of obsessive-compulsive disorder(OCD).Methods:Fifty-six patients with OCD were randomized to two groups.The patients(n=28)in observed group were treated with Relaxation training combined with Paroxetine.The patients(n=28)in control group were treated with Paroxetine alone.The efficacy and safety were assessed with Y-BOCS,CGI-SI,HAMD and TESS scales.Results:The scores of Y-BOCS,CGI-SI and HAMD scales in observed group were significantly lower than that in control group at the end of 4 weeks,8 weeks and 6 month after the treatment(P0.05,respectively).There was no significant difference in side effects between the two groups(P0.05).Conclusion:Relaxation training combined with Paroxetine was more effective than Paroxetine mono-therapy in thetreatment of OCD.
    Paroxetine
    Relaxation Therapy
    Citations (0)
    观察临床的功效和 Paroxetine 的不利反应的目的在对待消沉与电镀物品针灸(EA ) 结合了。有消沉的 42 个病人随机被分到与 EA 对待的观察组(22 个病人) 的方法与 Paroxetine,和独自与 Paroxetine 对待的控制组(20 个病人) 结合了,并且为两个组的治疗学的功课是 6 个星期。治疗效能和不利反应被哈密尔顿消沉规模(HAMD ) 和突现的症状放大的治疗(TESS ) 分别地与分数评估。在结束决定的结果 HAMD 分数第一,第二,治疗功课的第 4,和第 6 星期比在控制组(P<0.05 ) 的那些在观察组是显著地更低的。在 6 星期的治疗的结束评估的重要改进率在控制组(72.7% 对 40.0%) 比那在观察组是显著地更高的。TESS 分数的有效差量都没在二个组之间被发现。与 Paroxetine 相结合的结论 EA 独自比 Paroxetine 的有更好临床的功效,与更温和的不利反应和效果的更快的开始。
    Paroxetine
    Depression
    Citations (0)
    Paroxetine is an antidepressant included in the group of selective serotonin reuptake inhibitors (SSRI) with antidepressant and anxiolytic properties. A rarely seen adverse effect of paroxetine is dermatological reactions. Commonly seen reactions to paroxetine are eczematous reactions and benign skin lesions in general, while some clinical pictures such as life-threatening Stevens–Johnson syndrome and toxic epidermal necrolysis can also be seen. A case of a female patient who developed urticaria during paroxetine use is discussed in this paper.
    Paroxetine
    Toxic Epidermal Necrolysis
    Serotonin reuptake inhibitor
    Paroxetine is a commonly used antidepressant with a safe side-effect profile. A case of paroxetine overdose (560 mg) is reported in an 18-year-old female who attempted suicide and recovered without any sequelae, requiring only supportive treatment. This report highlights a case of pure paroxetine overdose and the safety profile of paroxetine in overdose.
    Paroxetine
    Drug overdose
    Citations (1)